Unknown

Dataset Information

0

Pediatric patients with immune-mediated diseases on immunosuppressants have low risk of severe COVID-19 and no increase in flare rate after SARS CoV-2 exposure.

ABSTRACT:

SUBMITTER: Cochino AV 

PROVIDER: S-EPMC9212399 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Pediatric patients with immune-mediated diseases on immunosuppressants have low risk of severe COVID-19 and no increase in flare rate after SARS CoV-2 exposure.

Cochino Alexis Virgil AV   Farkas Oana Maria OM   Ioan Andreea A  

The Journal of infection 20220618 3

Similar Datasets

Unknown Exposure to SARS-CoV-2 and Infantile Diseases.
| S-EPMC10154082 | biostudies-literature
Unknown Association between immunosuppressants and poor antibody responses to SARS-CoV-2 vaccines in patients with autoimmune liver diseases.
| S-EPMC9579272 | biostudies-literature
Unknown Severe pediatric acute encephalopathy syndromes related to SARS-CoV-2.
| S-EPMC10008884 | biostudies-literature
Unknown A public health antibody screening indicates a marked increase of SARS-CoV-2 exposure rate in children during the second wave.
| S-EPMC8018829 | biostudies-literature
Unknown Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccine.
| S-EPMC8748531 | biostudies-literature
Unknown Public Policy Measures to Increase Anti-SARS-CoV-2 Vaccination Rate in Russia.
| S-EPMC8955973 | biostudies-literature
Unknown Pediatric Inflammatory Multisystem Syndrome and Rheumatic Diseases During SARS-CoV-2 Pandemic.
| S-EPMC7746854 | biostudies-literature
Unknown Disease Flare and Reactogenicity in Patients With Rheumatic and Musculoskeletal Diseases Following Two-Dose SARS-CoV-2 Messenger RNA Vaccination.
| S-EPMC8712346 | biostudies-literature
Unknown Acute onset psychiatric diseases after SARS-CoV-2 virus infection among pediatric patients.
| S-EPMC11496280 | biostudies-literature
Unknown The Flare of Rheumatic Disease After SARS-CoV-2 Vaccination: A Review.
| S-EPMC9289284 | biostudies-literature